Position in GILD
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$450,149
-$46,426 QoQ
Shares Held
3,563
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,422
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rodgers Brothers Inc. holds $137,046,562 across 11 Drug Manufacturers - General names. GILD ranks #9 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
55,538 | $66,613,948 | |
| 2 | ABBV |
AbbVie Inc.
|
127,464 | $32,075,040 | |
| 3 | JNJ |
Johnson & Johnson
|
63,682 | $16,173,317 | |
| 4 | MRK |
Merck & Co., Inc.
|
102,689 | $13,195,536 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
79,062 | $4,555,552 | |
| 6 | NVO |
Novo Nordisk A S
|
42,450 | $2,035,053 | |
| 7 | PFE |
Pfizer Inc
|
33,453 | $805,548 | |
| 8 | AMGN |
Amgen Inc
|
1,897 | $686,941 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $450,149 | 3,563 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $496,575 | 3,563 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $437,322 | 3,563 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $395,493 | 3,563 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $395,029 | 3,563 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $413,240 | 3,688 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $340,660 | 3,688 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $315,070 | 3,758 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $257,836 | 3,758 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $273,808 | 3,738 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $302,815 | 3,738 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $302,607 | 4,038 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $239,918 | 3,113 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $246,835 | 2,975 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $255,403 | 2,975 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,654,834 | 26,825 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,744,587 | 28,225 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,689,866 | 28,425 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,114,766 | 29,125 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,027,396 | 29,025 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,984,889 | 28,825 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $625,295 | 9,675 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $563,665 | 9,675 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $766,178 | 12,125 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $259,672 | 3,375 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $327,075 | 4,375 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||